Ghrelin and neurohumoral antagonists in the treatment of cachexia associated with cardiopulmonary disease
- PMID: 16880713
- DOI: 10.2169/internalmedicine.45.1867
Ghrelin and neurohumoral antagonists in the treatment of cachexia associated with cardiopulmonary disease
Comment on
-
Ghrelin, a novel growth hormone-releasing peptide, in the treatment of cardiopulmonary-associated cachexia.Intern Med. 2006;45(3):127-34. doi: 10.2169/internalmedicine.45.1402. Epub 2006 Mar 1. Intern Med. 2006. PMID: 16508225 Review.
Similar articles
-
Ghrelin, a novel growth hormone-releasing peptide, in the treatment of cardiopulmonary-associated cachexia.Intern Med. 2006;45(3):127-34. doi: 10.2169/internalmedicine.45.1402. Epub 2006 Mar 1. Intern Med. 2006. PMID: 16508225 Review.
-
Cachexia in chronic heart failure: prognostic implications and novel therapeutic approaches.Curr Heart Fail Rep. 2005 Dec;2(4):198-203. doi: 10.1007/BF02696650. Curr Heart Fail Rep. 2005. PMID: 16332313 Review.
-
Treatment of cachexia with ghrelin in patients with COPD.Chest. 2005 Sep;128(3):1187-93. doi: 10.1378/chest.128.3.1187. Chest. 2005. PMID: 16162705
-
Ghrelin improves left ventricular dysfunction and cardiac cachexia in heart failure.Curr Opin Pharmacol. 2003 Apr;3(2):146-51. doi: 10.1016/s1471-4892(03)00013-4. Curr Opin Pharmacol. 2003. PMID: 12681236 Review.
-
Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure.Circulation. 2004 Dec 14;110(24):3674-9. doi: 10.1161/01.CIR.0000149746.62908.BB. Epub 2004 Nov 29. Circulation. 2004. PMID: 15569841 Clinical Trial.
Cited by
-
[Percutaneous aortic valve replacement - pro].Herz. 2009 Mar;34(2):124-9. doi: 10.1007/s00059-009-3213-x. Herz. 2009. PMID: 19370328 Review. German.
-
The burden of chronic obstructive pulmonary disease in patients hospitalized with heart failure.Wien Klin Wochenschr. 2009;121(9-10):309-13. doi: 10.1007/s00508-009-1185-8. Wien Klin Wochenschr. 2009. PMID: 19562292
-
Body mass index and prognosis in patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease.J Cachexia Sarcopenia Muscle. 2011 Jun;2(2):81-86. doi: 10.1007/s13539-011-0023-9. Epub 2011 Mar 1. J Cachexia Sarcopenia Muscle. 2011. PMID: 21766053 Free PMC article.
-
Neurohormonal activation and inflammation in chronic cardiopulmonary disease: a brief systematic review.Wien Klin Wochenschr. 2009;121(9-10):293-6. doi: 10.1007/s00508-009-1194-7. Wien Klin Wochenschr. 2009. PMID: 19562289
-
An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease.Am J Respir Crit Care Med. 2014 May 1;189(9):e15-62. doi: 10.1164/rccm.201402-0373ST. Am J Respir Crit Care Med. 2014. PMID: 24787074 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources